New Drug Combats Multidrug Resistant Tuberculosis

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 113, Nº. 4, 2013, págs. 29-30
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * Bedaquiline (Sirturo) is a new drug to treat multidrug-resistant pulmonary tuberculosis. It is administered as part of multidrug therapy when other antitubercular therapy cannot be used.

    * Bedaquiline increases the risk of death and can prolong the QT interval, producing serious ventricular arrhythmias.